SCPH: scPharmaceuticals Inc. Net Sales Margin

Brandmark of scpharmaceuticals.com (SCPH)

Patents for furosemide delivery systems provide scPharmaceuticals Inc. (SCPH) with a significant competitive advantage. Net profit margin on GURU.Markets demonstrates stability, with the indicator fixed at -183.60. Current capital fully covers operating expenses. Future growth is based on insurance company approvals and the successful implementation of home injections for cardiology patients.

scPharmaceuticals (SCPH) - Net Sales Margin from 07/04/2022 to 10/18/2025

Analytical breakdowns and data insights for company scpharmaceuticals.com (SCPH)

- market value and analyst target forecast:
Initial company analysis:scpharmaceuticals.com - SCPH
Manufactured product of scPharmaceuticals Inc.

This indicator is calculated as the ratio of net income to total revenue, determining the portion of every dollar of income remaining for scPharmaceuticals Inc. (SCPH) after all expenses. By analyzing the adjusted net profit margin on GURU.Markets, an investor can assess how effectively the expansion of Furoscix insurance coverage converts market demand into actual profit while mitigating operational production risks.

Main competitors

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Profit Rate TECX|tonixpharma.com - Net Sales Margin|Net Profit Rate SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Net Margin|Return on Sales by Net Profit BioHarvest|Return on Sales by Net Profit EXOZ|Return on Sales by Net Profit Oramed Pharmaceuticals (ORMP)|Return on Sales by Net Profit ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Net Return on Sales|Net Sales Margin ABVC (ABVC BioPharma Inc)|CPIX - Return on Sales by Net Profit|Quantum BioPharma Corp - Net Sales Margin|FGEN (fibrogen.com) - Net Return on Sales|TELO (Telomir Pharmaceuticals) - Return on Sales by Net Profit|Rani Therapeutics Holdings - Net Profit Rate|Return on Sales by Net Profit SNYR|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma